GuaiAid brand guaifenesin is now the center of anguish. As far as I can tell it is entirely short-acting. If it is “medium-acting” as some are claiming, let’s see the proof and the approval of data from the Federal Drug Administration. It should have to withstand all the rigors other products have had to face to prove the duration of their action.
I have seen a high failure rate in patients attempting to use only short-acting products (including Guai-Aid) no matter who makes them. This has been demonstrated by my examination of patients (mapping) enough times for me to feel secure in saying that the failure rate using Guai-Aid is unacceptably high.
That’s why I begin all of my patients on extended release guaifenesin tablets. These work smoothly over twelve hours. Extended release tablets can be safely cut with a pill cutter, but only do it once. A 600 mg. tablet can thus yield the beginner's dose of 300 mg. twice a day. A 1200 mg. tablet can be cut to yield two 600 mg. doses (but do not cut a 1200 mg. tablet to make 300 mg. doses.)
All extended release white guaifenesin tablets will reverse fibromyalgia if taken at the proper dosage and as long as a patient is not blocked by salicylates. Currently the best price is available through amazon.com on bulk bottles (#500) of the Guardian 600 mg. tablets. We expect to see more brands on the market soon because the patent has expired on Mucinex.
We have previously warned patients not to use Mucinex because of the specific blue dye they use, which can inhibit energy production.
Fibropharmacy sells extended release tablets as well as capsules (300mg and 600mg) that have proven to be effective. (DO NOT PURCHASE THE CAPLETS. THESE ARE GUAI AID). The drawback with the capsules is their price but if patients wish to use a capsule these are still acceptable.
To those from whatever group claims pure success, I can say “you’re wrong”. To leaders of whatever group who squash discussions or observations about failures, I repeat “you’re wrong”. I’ve learned from sixty years treating patients and hard study, but equally from patient inputs and their personal observations. We have no axe to grind. We own or sell nothing. We own no pharmacies or stock in drug companies. We get no kick-backs.
The preceding is my position and on my honor I will uphold it until the end of my professional life.
Unfortunately, those who mistakenly splinter the protocol may well succeed in the end. Claudia and I have only a short run left and some of these individuals and support groups may well be in control. They will either help save fibromyalgia patients or guide them into an unacceptably high rate of failure.
-R. Paul St. Amand, M.D.
I have seen a high failure rate in patients attempting to use only short-acting products (including Guai-Aid) no matter who makes them. This has been demonstrated by my examination of patients (mapping) enough times for me to feel secure in saying that the failure rate using Guai-Aid is unacceptably high.
That’s why I begin all of my patients on extended release guaifenesin tablets. These work smoothly over twelve hours. Extended release tablets can be safely cut with a pill cutter, but only do it once. A 600 mg. tablet can thus yield the beginner's dose of 300 mg. twice a day. A 1200 mg. tablet can be cut to yield two 600 mg. doses (but do not cut a 1200 mg. tablet to make 300 mg. doses.)
All extended release white guaifenesin tablets will reverse fibromyalgia if taken at the proper dosage and as long as a patient is not blocked by salicylates. Currently the best price is available through amazon.com on bulk bottles (#500) of the Guardian 600 mg. tablets. We expect to see more brands on the market soon because the patent has expired on Mucinex.
We have previously warned patients not to use Mucinex because of the specific blue dye they use, which can inhibit energy production.
Fibropharmacy sells extended release tablets as well as capsules (300mg and 600mg) that have proven to be effective. (DO NOT PURCHASE THE CAPLETS. THESE ARE GUAI AID). The drawback with the capsules is their price but if patients wish to use a capsule these are still acceptable.
To those from whatever group claims pure success, I can say “you’re wrong”. To leaders of whatever group who squash discussions or observations about failures, I repeat “you’re wrong”. I’ve learned from sixty years treating patients and hard study, but equally from patient inputs and their personal observations. We have no axe to grind. We own or sell nothing. We own no pharmacies or stock in drug companies. We get no kick-backs.
The preceding is my position and on my honor I will uphold it until the end of my professional life.
Unfortunately, those who mistakenly splinter the protocol may well succeed in the end. Claudia and I have only a short run left and some of these individuals and support groups may well be in control. They will either help save fibromyalgia patients or guide them into an unacceptably high rate of failure.
-R. Paul St. Amand, M.D.
RSS Feed